# Formula Systems (1985) Ltd: financial statements, quarterly

FORTY · Nasdaq · CIK 1045986 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/forty.md) · [Financials](/companies/forty/financials.md) · [Filings](/companies/forty/filings.md) · [Insiders](/companies/forty/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/forty/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2013 (2013-12-31) | FY2014 (2014-12-31) | FY2015 (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [82.1](/filings/0001144204-16-102542.md) | [107](/filings/0001144204-16-102542.md) | [133](/filings/0001144204-16-102542.md) | [240](/filings/0001213900-20-016071.md) | [246](/filings/0001213900-21-027074.md) | [268](/filings/0001213900-22-027668.md) | [369](/filings/0001213900-23-094521.md) | [502](/filings/0001213900-23-094521.md) | [485](/filings/0001213900-23-094521.md) | [544](/filings/0001213900-24-043687.md) | [452](/filings/0001213900-25-043461.md) | [508](/filings/0001213900-25-043461.md) |
| Current assets | $m | [333](/filings/0001144204-15-026652.md) | [358](/filings/0001144204-16-102542.md) | [357](/filings/0001144204-16-102542.md) | [634](/filings/0001213900-18-006332.md) | [695](/filings/0001213900-19-008675.md) | [781](/filings/0001213900-20-016071.md) | [966](/filings/0001213900-21-027074.md) | [1,161](/filings/0001213900-22-027668.md) | [1,302](/filings/0001213900-23-094521.md) | [1,371](/filings/0001213900-24-043687.md) | [1,376](/filings/0001213900-25-043461.md) | [1,487](/filings/0001213900-25-043461.md) |
| Total assets | $m | [872](/filings/0001144204-15-026652.md) | [1,125](/filings/0001144204-16-102542.md) | [1,067](/filings/0001144204-16-102542.md) | [1,355](/filings/0001213900-18-006332.md) | [1,564](/filings/0001213900-19-008675.md) | [1,665](/filings/0001213900-20-016071.md) | [2,089](/filings/0001213900-21-027074.md) | [2,520](/filings/0001213900-22-027668.md) | [2,749](/filings/0001213900-23-094521.md) | [2,794](/filings/0001213900-24-043687.md) | [2,813](/filings/0001213900-25-043461.md) | [3,015](/filings/0001213900-25-043461.md) |
| Current liabilities | $m | [211](/filings/0001144204-15-026652.md) | [227](/filings/0001144204-16-102542.md) | [212](/filings/0001144204-16-102542.md) | [359](/filings/0001213900-18-006332.md) | [433](/filings/0001213900-19-008675.md) | [526](/filings/0001213900-20-016071.md) | [671](/filings/0001213900-21-027074.md) | [780](/filings/0001213900-22-027668.md) | [948](/filings/0001213900-23-094521.md) | [1,001](/filings/0001213900-24-043687.md) | [986](/filings/0001213900-25-043461.md) | [1,138](/filings/0001213900-25-043461.md) |
| Total liabilities | $m | [396](/filings/0001144204-15-026652.md) | [468](/filings/0001144204-16-102542.md) | [504](/filings/0001144204-16-102542.md) | [56.7](/filings/0001213900-18-006332.md) | [59.2](/filings/0001213900-19-008675.md) | [7.1](/filings/0001213900-20-016071.md) | [14.0](/filings/0001213900-20-016071.md) | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [0.0](/filings/0001144204-14-026077.md) | [0.0](/filings/0001144204-16-102542.md) | [58.3](/filings/0001144204-16-102542.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001144204-14-026077.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [319](/filings/0001144204-15-026652.md) | [390](/filings/0001144204-16-102542.md) | [452](/filings/0001144204-16-102542.md) | [336](/filings/0001213900-18-006332.md) | [359](/filings/0001213900-19-008675.md) | [368](/filings/0001213900-20-016071.md) | [422](/filings/0001213900-21-027074.md) | [503](/filings/0001213900-22-027668.md) | [541](/filings/0001213900-23-094521.md) | [552](/filings/0001213900-24-043687.md) | [626](/filings/0001213900-25-043461.md) | [679](/filings/0001213900-25-043461.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Current assets: us-gaap:AssetsCurrent, ifrs-full:CurrentAssets
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent, ifrs-full:CurrentLiabilities
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 15,332,667 at 2025-12-31, from the cover of the [20-F filed 2026-05-13](/filings/0001213900-26-055948.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.